New hope for Hard-to-Treat blood cancers: SLS009 trial launches

NCT ID NCT04588922

Recruiting now Disease control Sponsor: Sellas Life Sciences Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 4 times

Summary

This study tests a new drug called SLS009, alone or with other medicines, in people with blood cancers like leukemia and lymphoma that have come back or not responded to treatment. It also includes newly diagnosed patients with high-risk leukemia. The goal is to see if the drug is safe and helps control the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia B-cell chronic lymphocytic leukemia hematopoietic and lymphoid system neoplasm lymphoma Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGIC MALIGNANCIES

Contacts and locations

Locations

Affiliated Cancer Hospital of Chongqing University
WITHDRAWN

Chongqing, Chongqing Municipality, China
Affiliated Hospital of Hebei University
COMPLETED

Baoding, Hebei, China
Anhui Provincial Hospital
COMPLETED

Hefei, Anhui, China
Baylor Scott & White Health
RECRUITING

Dallas, Texas, 75246, United States
Blood disease hospital, Chinese Academy of Medical Science
COMPLETED

Tianjin, Tianjin Municipality, 300000, China
Bon Secours St. Francis Cancer Center
RECRUITING

Greenville, South Carolina, 29607, United States
Cancer prevention and treatment center of Sun Yat sen University
COMPLETED

Guangzhou, Guangdong, China
City of Hope - Atlanta
RECRUITING

Newnan, Georgia, 30265, United States
City of Hope - Chicago
RECRUITING

Zion, Illinois, 60099, United States
City of Hope - Phoenix
RECRUITING

Goodyear, Arizona, 85338, United States
City of Hope National Medical Center
RECRUITING

Duarte, California, 91010, United States
Clinical Research Alliance, Inc.
TERMINATED

Lake Success, New York, 11042, United States
Guangdong Provincial People's Hospital
COMPLETED

Guangzhou, Guangdong, China
Henan Cancer Hospital
COMPLETED

Zhengzhou, Henan, 450000, China
Linyi Cancer Hospital
COMPLETED

Linyi, Shandong, China
MD Anderson
RECRUITING

Houston, Texas, 77091, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
New York - Presbyterian Hospital
TERMINATED

New York, New York, 10032, United States
O'Neal Comprehensive Cancer Center, University of Alabama
RECRUITING

Birmingham, Alabama, 35233, United States
Ochsner Clinic Foundation
TERMINATED

New Orleans, Louisiana, 70121, United States
Shengjing Hospital Affiliated to China Medical University
COMPLETED

Shenyang, Liaoning, China
The First Affiliated Hospital Of Nanchang University
COMPLETED

Nanchang, Jiangxi, China
The First Affiliated Hospital of Bengbu Medical College
COMPLETED

Bengbu, Anhui, China
The First Affiliated Hospital of Soochow University
COMPLETED

Suzhou, Jiangsu, China
The Second Affiliated hospital of Zhejiang University School of Medicine
COMPLETED

Hangzhou, Zhejiang, 310000, China
UNC School of Medicine, Division of Hematology
RECRUITING

Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.